Healthcare
iOrganBio Appoints AI and Life Sciences Investor Jessica Owens to Board of Directors
iOrganBio has appointed Jessica Owens, a seasoned venture investor and co-founder of GRAIL, to its board to help scale its AI-driven cell manufacturing platform.
DOJ Launches Task Force to Curb Tech-Driven Health Care Fraud on West Coast
The U.S. Department of Justice announced a task force targeting tech-driven health care fraud in California, Arizona, and Nevada, aiming to dismantle digital health schemes and improve conditions for legitimate providers like Astiva Health.
AI-Powered Wearables Poised to Transform Healthcare with Actionable Insights
Advances in artificial intelligence are enabling wearable devices to provide clinicians with actionable insights, moving beyond data collection to drive meaningful healthcare improvements.
KALA BIO Implements 1-for-50 Reverse Stock Split, Reducing Outstanding Shares from 929.5 Million to 18.6 Million
KALA BIO executed a 1-for-50 reverse stock split to meet Nasdaq listing requirements and consolidate its capital structure, effective May 11, 2026.
Pipeline Maturity Reshapes Biotech Valuations as Clinical Progress Gains Weight
The biotechnology industry's valuation model is shifting from a revenue-centric approach to one that prioritizes clinical-stage progression and probability of success, with companies like Oncotelic Therapeutics exemplifying this trend.
Gillian Ragan Foundation to Host First Community Fundraiser at Pinnacle Brewing Company
The Gillian Ragan Foundation, supporting families who lost a child, will hold its inaugural fundraiser on May 17, 2026, featuring a hybrid silent auction to fund mental health therapy and grief counseling.
MedCognetics and AWS Partner to Bring AI-Powered Breast Cancer Screening to Underserved Indian Communities
MedCognetics collaborates with AWS and Health Within Reach Foundation to deploy AI-enabled mobile mammography units in India, aiming to reduce breast cancer disparities in underserved populations.
Lantern Pharma Unveils Multi-Agent AI and Computational Biology Tools for withZeta.ai Platform
Lantern Pharma announced the next phase of its withZeta.ai platform, including ZetaSwarm and ZetaOmics, which could accelerate oncology research and create a new revenue stream for the company.
Silo Pharma Launches Ibogaine-Based TBI Therapeutics Initiative
Silo Pharma announced a strategic initiative to develop ibogaine-based therapeutics for traumatic brain injury and related conditions, filing a provisional patent application.
NextPlat Corp to Report First-Quarter 2026 Financial Results on May 14
NextPlat Corp announced it will release its Q1 2026 financial results on May 14, 2026, providing investors with key insights into the company's performance in its e-commerce and healthcare solutions segments.
Oragenics Signs LOI to License CardioDialysis Technology for Brain Disorders
Oragenics Inc. has signed a letter of intent to license Sigyn Therapeutics' CardioDialysis blood purification technology, aiming to combine it with its intranasal neurosteroid candidate ONP-002 for a dual-modality approach to traumatic brain injury and neurodegenerative diseases.
HeartBeam Expands Concierge Cardiology Footprint with Atelier Health Agreement
HeartBeam Inc. has signed a commercial agreement with Beverly Hills-based Atelier Health, expanding its launch footprint into Southern California and completing its initial targeted markets for its cable-free 3D ECG technology.
Hantavirus Outbreak on Cruise Ship Raises Concerns Over Little-Known Infection
A hantavirus outbreak on the MV Hondius cruise ship has resulted in three fatalities, highlighting the need for awareness and diagnostic solutions for this rare but deadly virus.
NanoViricides to Present at D. Boral Capital Global Conference Amid Progress on Broad-Spectrum Antiviral NV-387
NanoViricides will participate in the D. Boral Capital Global Conference, highlighting its clinical-stage antiviral drug NV-387 and its potential to treat multiple viral infections including RSV, COVID, and Monkeypox.
Annovis Bio CEO to Present Multi-Protein Approach to Alzheimer's at Fierce Biotech Week 2026
Annovis Bio CEO will present the company's multi-protein targeting strategy for Alzheimer's disease at Fierce Biotech Week 2026, highlighting buntanetap's Phase 3 trial.
Wellness Index Report Highlights Shift from Seasonal Diets to Cellular Health as Superhuman Protocol Challenge Gains Traction
The April 2026 Wellness Index Report reveals a consumer shift from short-term weight loss to cellular-level health optimization, spotlighting the Superhuman Protocol Challenge and three top-rated providers.
Wellness Index Report Reveals Top Providers in Superhuman Protocol Challenge, Marking Shift to Cellular-Level Health
The April 2026 Wellness Index Report identifies Physical Evidence Chiropractic, Boro Holistic Health, and April Berkowitz as leading providers in the Superhuman Protocol Challenge, signaling a move from seasonal weight-loss trends to system-level health optimization.
AI and Multi-Omics Converge: Cardio Diagnostics Targets Earlier, More Precise Cardiac Insights
Cardio Diagnostics Holdings is leveraging artificial intelligence and multi-omic biomarkers to improve early detection and personalized treatment of cardiovascular disease, addressing a critical gap in traditional risk assessment.
Tonix Pharmaceuticals Secures GPO Agreement Covering 35 Million Lives for TONMYA Fibromyalgia Treatment
Tonix Pharmaceuticals announced a group purchasing organization agreement effective May 1, 2026, covering approximately 35 million U.S. commercial lives for its FDA-approved non-opioid fibromyalgia treatment TONMYA, expanding patient access.
Oncotelic Therapeutics Completes $12.5M Asset Transfer to Lunai Bioworks, Focusing on Nose-to-Brain Delivery for Alzheimer's and Biodefense
Oncotelic Therapeutics has transferred worldwide rights to its nose-to-brain delivery system for Alzheimer's and biodefense to Lunai Bioworks in exchange for $12.5 million in preferred stock, enabling it to monetize assets while retaining control for other indications like Parkinson's disease.
Blocking Fructose Metabolism Shows Promise Against Pediatric Brain Cancer
New research from Johns Hopkins reveals that disrupting fructose metabolism in tumor cells could slow group 3 medulloblastoma, a deadly childhood brain cancer, offering a potential new treatment avenue.
BioAdaptives Launches Nighttime Supplement Targeting Sleep and Cognitive Recovery
BioAdaptives launches MyndRenew, a nighttime supplement to support sleep and brain recovery, addressing the widespread issue of insufficient sleep among U.S. adults.
VolitionRx Reports High Accuracy in Feline Cancer Blood Test, Unlocking $5M Milestone
VolitionRx's Nu.Q Vet prototype assay shows 97% specificity in detecting feline lymphoma, advancing a liquid biopsy for cats and unlocking a $5 million contractual milestone upon peer-reviewed publication.
Aclarion Expands Commercial Team Amid Triple-Digit Growth in Nociscan Utilization
Aclarion granted inducement stock options to its new Western U.S. Commercial Director as demand for its Nociscan platform surges, reflecting strong adoption of its AI-driven chronic low back pain diagnostic tool.
HeartBeam Targets Heart Disease with Advanced ECG Technology as Cardiovascular Deaths Surge
HeartBeam Inc. is developing next-generation ECG solutions to address the gap in early cardiac detection, as cardiovascular disease remains the leading cause of death in the U.S. with over 919,000 deaths in 2023.
New Study Reveals How Cancer Reprograms Immune Cells, Offering Hope for Immunotherapy Breakthrough
A study uncovering how cancer cells reprogram immune cells to support tumor growth could improve immunotherapy response rates, which currently fail in 80% of patients.
MilliporeSigma Expands Temecula Biotech Hub, Advancing Organoid Research and Personalized Medicine
MilliporeSigma's investments in Temecula, including a new organoid lab and acquisition of HUB Organoids, position the site at the forefront of disease modeling and personalized medicine, while reinforcing its community commitment.
MindBio Therapeutics Develops Cross-Language AI Model for Intoxication Detection, Expanding Non-Invasive Safety Screening
MindBio Therapeutics has created a language-agnostic AI speech model that detects drug and alcohol intoxication across multiple languages, enabling scalable, non-invasive testing for high-volume safety screening in industries like mining, aviation, and construction.
Oragenics Advances Phase IIa Trial for Concussion Treatment, Targeting Data Readout by 2026
Oragenics Inc. is actively enrolling patients at a second site in its Phase IIa trial for ONP-002, a potential first-in-class treatment for concussion, with a data readout expected by end of 2026.
SS Innovations Surpasses 10,500 Surgeries with SSi Mantra Robotic System, Signaling Growing Global Adoption
SS Innovations International announced that its SSi Mantra surgical robotic system has been used in over 10,500 procedures across 11 countries, highlighting the system's rapid adoption and potential to democratize robotic surgery.